| Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine C Pauli, BD Hopkins, D Prandi, R Shaw, T Fedrizzi, A Sboner, V Sailer, ... Cancer discovery 7 (5), 462-477, 2017 | 889 | 2017 |
| Dual roles of PARP-1 promote cancer growth and progression MJ Schiewer, JF Goodwin, S Han, JC Brenner, MA Augello, JL Dean, ... Cancer discovery 2 (12), 1134-1149, 2012 | 464 | 2012 |
| FOXA1: master of steroid receptor function in cancer MA Augello, TE Hickey, KE Knudsen The EMBO journal 30 (19), 3885-3894, 2011 | 213 | 2011 |
| SPOP mutation drives prostate tumorigenesis in vivo through coordinate regulation of PI3K/mTOR and AR signaling M Blattner, D Liu, BD Robinson, D Huang, A Poliakov, D Gao, S Nataraj, ... Cancer cell 31 (3), 436-451, 2017 | 209 | 2017 |
| N-Myc–mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer A Berger, NJ Brady, R Bareja, B Robinson, V Conteduca, MA Augello, ... The Journal of clinical investigation 129 (9), 3924-3940, 2019 | 150 | 2019 |
| Targeting cell cycle and hormone receptor pathways in cancer CES Comstock, MA Augello, JF Goodwin, R De Leeuw, MJ Schiewer, ... Oncogene 32 (48), 5481-5491, 2013 | 117 | 2013 |
| CHD1 loss alters AR binding at lineage-specific enhancers and modulates distinct transcriptional programs to drive prostate tumorigenesis MA Augello, D Liu, LD Deonarine, BD Robinson, D Huang, S Stelloo, ... Cancer Cell 35 (4), 603-617. e8, 2019 | 111 | 2019 |
| MAPK reliance via acquired CDK4/6 inhibitor resistance in cancer R De Leeuw, C McNair, MJ Schiewer, NP Neupane, LJ Brand, ... Clinical Cancer Research 24 (17), 4201-4214, 2018 | 109 | 2018 |
| Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer CES Comstock, MA Augello, RP Benito, J Karch, TH Tran, FE Utama, ... Clinical Cancer Research 15 (17), 5338-5349, 2009 | 106 | 2009 |
| AR function in promoting metastatic prostate cancer MA Augello, RB Den, KE Knudsen Cancer and Metastasis Reviews 33, 399-411, 2014 | 92 | 2014 |
| Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene NA Olshavsky, CES Comstock, MJ Schiewer, MA Augello, T Hyslop, ... Cancer Research 70 (10), 3975-3984, 2010 | 75 | 2010 |
| The AR dependent cell cycle: mechanisms and cancer relevance MJ Schiewer, MA Augello, KE Knudsen Molecular and cellular endocrinology 352 (1-2), 34-45, 2012 | 67 | 2012 |
| Identifying synergistic high-order 3D chromatin conformations from genome-scale nanopore concatemer sequencing AS Deshpande, N Ulahannan, M Pendleton, X Dai, L Ly, JM Behr, ... Nature Biotechnology 40 (10), 1488-1499, 2022 | 64 | 2022 |
| Personalized In vitro and C Pauli, BD Hopkins, D Prandi, R Shaw, T Fedrizzi, A Sboner, V Sailer, ... Vivo Cancer Models to Guide Precision Medicine, In: Cancer Discov. 2017; 7 …, 2017 | 61 | 2017 |
| Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes MA Augello, CJ Burd, R Birbe, C McNair, A Ertel, MS Magee, DE Frigo, ... The Journal of clinical investigation 123 (1), 2012 | 51 | 2012 |
| Cyclin D1 is a selective modifier of androgen-dependent signaling and androgen receptor function CES Comstock, MA Augello, MJ Schiewer, J Karch, CJ Burd, A Ertel, ... Journal of Biological Chemistry 286 (10), 8117-8127, 2011 | 49 | 2011 |
| mTOR is a selective effector of the radiation therapy response in androgen receptor-positive prostate cancer MJ Schiewer, R Den, DT Hoang, MA Augello, YR Lawrence, AP Dicker, ... Endocrine-related cancer 19 (1), 1, 2012 | 47 | 2012 |
| Cell cycle-coupled expansion of AR activity promotes cancer progression C McNair, A Urbanucci, CES Comstock, MA Augello, JF Goodwin, ... Oncogene 36 (12), 1655-1668, 2017 | 42 | 2017 |
| Aberrant BAF57 signaling facilitates prometastatic phenotypes S Balasubramaniam, CES Comstock, A Ertel, KW Jeong, MR Stallcup, ... Clinical cancer research 19 (10), 2657-2667, 2013 | 39 | 2013 |
| Reshaping of the androgen-driven chromatin landscape in normal prostate cells by early cancer drivers and effect on therapeutic sensitivity I Grbesa, MA Augello, D Liu, DR McNally, CD Gaffney, D Huang, K Lin, ... Cell reports 36 (10), 2021 | 26 | 2021 |
